[Applicability of sentinel-lymph-node detection and biopsy in the treatment of vulval cancer]
Atienza Merino G
Record ID 32010000673
To assess the percentage of sentinel-lymph-node detection in vulval cancer and the diagnostic accuracy of the test, by determination of its sensitivity and negative predictive value (NPV); and, to ascertain the adverse effects of this technology and long term relapses of tumour.
The sentinel-lymph-node detection and false negative percentages, together with the sensitivity and negative predictive values, render this technique comparable to that of sentinel-lymph-node detection in breast cancer. Factors such as multidisciplinary team, patient selection, primary tumour site, anatomopathological technique used and learning curve areconsidered critical when implementing the technique. The recidivation rate is similar to that described with classic lymphadenectomy and displays fewer sideeffects, both short- and long-term.
English language abstract:
An English language summary is available
- Lymphatic Metastasis
- Sentinel Lymph Node Biopsy
- Vulvar Neoplasms
Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
Conselleria de Sanidade, Xunta de Galicia, San Lazaro s/n 15781 Santiago de Compostela, Spain. Tel: 34 981 541831; Fax: 34 981 542854;
Galician Agency for Health Technology Assessment (AVALIA-T)